Get started
Author

Raymond R. Yin

IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia
2020 · Tian Yi Zhang, Ritika Dutta, et al. · Science Translational Medicine · 78
Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2
2020 · Ritika Dutta, Tian Yi Zhang, et al. · Journal of Clinical Investigation · 27
PDF
Instrument and Supply Variability: An Opportunity to Reduce the Carbon Footprint of the Operating Room
2023 · Tejas S. Sathe, Thomas A. Sorrentino, et al. · Journal of Surgical Research · 13
PDF
Functional donor-site morbidity following reconstruction with pectoralis major flaps: A systematic review
2024 · Israel O. Falade, Alexander I. Murphy, et al. · JPRAS Open · 7
Efficacy of the Modified 5-Item Frailty Index in Predicting Surgical-Site Infections in Patients Undergoing Breast Implant Augmentation: A National Surgical Quality Improvement Project-Based 5-Year Study
2023 · Helen Liu, Arya Akhavan, et al. · Aesthetic Surgery Journal Open Forum · 7
PDF
Circulating Tumor DNA (ctDNA) Enables Superior and Universal Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) Highly Predictive of Relapse Free and Overall Survival
2024 · Ruwan Gunaratne, Crystal Zhou, et al. · Blood · 5
Patient-Directed Discharge in Hand Infection Cases
2025 · Daniel Soroudi, Micaela Rosser, et al. · Annals of Plastic Surgery · 2
Evaluating the quality and reliability of oncologic breast reconstruction videos on youtube
2024 · Daniel Soroudi, Israel Falade, et al. · JPRAS Open · 2
PDF
The Utility of Prevena Negative Pressure Wound Therapy on Groin Incisions for Critical Limb-Threatening Ischemia
2024 · Raymond Yin, Alexis Gursky, et al. · Annals of Plastic Surgery · 2
Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
2023 · Ruwan Gunaratne, Crystal Zhou, et al. · Blood · 2
Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al. · Blood Cancer Discovery · 1
Risk Factors for Developing Community-Acquired Hand Infections at a Large-Volume Urban Safety Net Hospital
2024 · Raymond Yin, Mica Rosser, et al. · Annals of Plastic Surgery · 1
Heterogeneous Definitions of Secondary Acute Myeloid Leukemia (AML) Yield Distinct Outcomes in Response to First-Line Treatment with Hypomethylating Agents (HMA) and Venetoclax (Ven)
2021 · Irena Tan, Matthew Schwede, et al. · Blood · 1
Supplementary Table S2 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Table S3 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Fig. S5 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Fig. S17 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Fig. S14 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Data 1 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Fig. S11 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Table S5 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Data from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Fig. S16 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Table S1 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Supplementary Fig. S7 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
2026 · Ruwan Gunaratne, Crystal M. Zhou, et al.
Works count: 45
Citation count: 148
H-index: 5
I10-index: 3
Year
Topic
Type